STAT

Just about every schoolchild learns that Napoleon Bonaparte was a small man. But few know that he cast as large a shadow over the history of medicine as over the nature of warfare. That’s because his surgeon-in-chief in the…

WASHINGTON — A Senate hearing Thursday provided one of the clearest roadmaps to date for how Senate Democrats plan to use their newfound majority to advance new health care policies. The hearing was scheduled to let lawmakers vet…

In an unusual move, Pacira Biosciences (PCRX) has filed a libel lawsuit against a medical journal, its editors, and the authors of several recently published papers, arguing the articles were based on “faulty scientific…

Thermo Fisher Scientific announced Thursday that it will buy PPD, a contract-research company for the pharmaceutical and biotech industries, in a deal valued at $17.4 billion, plus the assumption of about $3.5 billion in debt. The…

In a searing rebuke, the Biden administration is formally withdrawing a last-minute proposal by the Trump administration to exempt a wide swath of medical devices and artificial intelligence tools from regulatory review. Officials with…

Amid mounting pressure to widen global access to Covid-19 vaccines, the head of the World Trade Organization laid out a series of steps that should be taken by vaccine makers, which have resisted a proposal that has spurred debate over…

Top of the morning to you. Gray skies are hovering over the Pharmalot campus right now, but our spirits remain sunny, nonetheless. Why? We will trot out a bit of insight from the Morning Mayor, who would say, ‘Every new day should…

Despite mounting concern over antibiotic resistance, a new report finds that none of 43 antibiotics currently in development target the most dangerous bacteria, making them insufficient to tackle the fast-growing public health threat.…

People living with amyotrophic lateral sclerosis, or ALS, in the U.S. will have to wait longer than their counterparts in Europe and Canada for access to a potentially beneficial treatment, even though the medicine is being developed…

For countries in Europe, negotiating a deal with a pharma company over drug prices is the equivalent of a David and Goliath matchup. Payers have little leverage to push back against prices and terms set by pharma companies, causing many…

The pace of innovation in wearable technology has never been faster. As often as once a year, major brands debut new devices, offering consumers sleeker and faster hardware and updated software. While consumers may get excited about the…

Arguing patient safety is at risk, an advocacy group is urging the Food and Drug Administration to create a new policy for updating an official list of medicines that are withdrawn after being deemed unsafe or ineffective. In a petition…

Rise and shine, another busy day is on the way. However, this is also shaping up as a beautiful day as well, given the clear and sunny skies — and delicious breezes — enveloping the Pharmalot campus this morning. This calls…

Hello, everyone, and welcome to the middle of the week. You made it this far, so why not continue, yes? Perhaps a cup or two of stimulation is in order. As you know, a prescription is not required. So feel free to indulge as you attack…

Cambridge biotech Tango Therapeutics is going public through a $353 million deal with a special purpose acquisition company, the precision cancer medicine firm announced Wednesday. The SPAC, called BCTG Acquisition Corp., is backed by…

Editors note: A livestream of the conversation will be embedded below at 1 p.m. ET. Sponsored By   Every week, STAT+ subscribers get access to exclusive conversations with biotech, pharma, and health tech leaders. This week, STAT…

WASHINGTON — Steve Ubl, who leads the drug industry lobbying powerhouse PhRMA, has a bold prediction: Democrats might control the House, Senate, and White House, but Covid-19 has given pharma the advantage in the debate over drug…

Mayo Clinic is forming a pair of companies to collect and analyze data from remote monitoring devices and diagnostic tools, a move that comes as part of a broader bid to harness patient data to deliver continuous care guided by…

In what is being called a win for consumers, a U.S. appeals court upheld a decision by the Federal Trade Commission that a so-called pay-to-delay deal between two drug makers was anti-competitive. At issue was a deal reached in 2010…

Revolution Medicines on Saturday presented updated data to bolster the case for its lead cancer drug — designed to stop tumor growth by throttling back mutations in a common cell-signaling pathway. The drug, called RMC-4630,…